The compound produced dose-dependent inhibition of stimulated expression of TRAIL protein.
Name | 6-Thioguanine | EINECS | 205-827-2 |
CAS No. | 154-42-7 | Density | 2.08 g/cm3 |
PSA | 119.28000 | LogP | 0.80500 |
Solubility | soluble in water | Melting Point | ≥300 °C(lit.)
|
Formula | C5H5N5S | Boiling Point | 555.4 °C at 760 mmHg |
Molecular Weight | 167.194 | Flash Point | 289.7 °C |
Transport Information | UN 2811 6.1/PG 3 | Appearance | Odorless or almost odorless pale yellow crystalline powder |
Appearance and properties: Odorless or almost odorless light yellow crystalline powder
Density: 2.08g /cm3
Boiling point: 123 (29 torr)
Melting point: ≥300 °C(lit.)
Flash point: 356ºC
Water solubility: soluble
Stability: Stable under normal temperatures and pressures.
Storage conditions: warehouse ventilation low temperature dry
Vapor pressure: 1.5E-17mmHg at 25°C
Usage
It is used for the prevention and treatment of coronary atherosclerosis and hepatitis. It is also used for leukopenia, primary thrombocytopenic purpura, acute anuria caused by chronic renal insufficiency, nephrotic syndrome, uremia and other metabolic adjuvant treatment.